Side-by-side facts
Prebiotic Products Compared: Substrate, Dose & Evidence Match
Compare prebiotic products by substrate, labeled dose, trial-dose match and product-specific evidence across XOS, FOS, GOS, PHGG, resistant starch and other fibers.
Key differences
Compare the substrate, dose and studied endpoint together. A product can contain a recognized prebiotic while still being a poor match for the trial cited for that ingredient.
| Comparison point | Bimuno Original | DaVinci Laboratories Arabinogalactan Powder | Layer Origin PureHMO 2'-FL Powder | MSPrebiotic Resistant Potato Starch RS2 | NOW Acacia Fiber Organic Powder | NOW NutraFlora FOS Powder | NOW Prebiotic Bifido Boost Powder | NOW Prebiotic Fiber with Fibersol-2 Powder | OatWell Original Oat Bran Powder | SFI Health / Klaire Labs Galactomune Powder | Tomorrow's Nutrition Sunfiber |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prebiotic substrateXOS, FOS, GOS, PHGG, resistant maltodextrin, acacia, HMOs, resistant starch and beta-glucans are not interchangeable. | Bimuno B-GOS galactooligosaccharidesSource | Larch tree (Larix laricina) extract yielding 85% arabinogalactansSource | 2'-fucosyllactose (2'-FL), a fermentation-produced human milk oligosaccharideSource | Potato-derived resistant starch type 2 (RS2)Source | Organic acacia gum powder from Acacia senegal / Acacia seyalSource | NutraFlora short-chain fructooligosaccharides (scFOS)Source | Xylooligosaccharides (XOS) from PreticX prebiotic complexSource | Fibersol-2 digestion-resistant maltodextrin derived from non-GMO cornSource | Oat beta-1,3/1,4-glucan in oat branSource | Galactooligosaccharides (GOS) complex plus beta-1,3/1,6-glucan purified from Saccharomyces cerevisiaeSource | Partially hydrolyzed guar gum (PHGG / guar fiber)Source |
| Labeled amountCompare grams or milligrams before borrowing evidence from a trial. | Comparable value not available | 5 g larch extract per scoop, yielding 4.25 g arabinogalactansSource | 2.0 g 2'-FL to startSource | 10 g scoop provides 7 g insoluble fiber; product should be mixed into cool foods or drinksSource | 6.5 g per tablespoon, providing 6 g soluble dietary fiberSource | 5 g per 2 teaspoonsSource | 2.2 g (2,200 mg) per level teaspoon; serving weighs about 3.4 gSource | 12 g Fibersol-2 per 2 tablespoons, providing 11 g dietary fiberSource | 3 g oat beta-glucan per 11 g scoop; product states 100% oat bran with 28% beta-glucanSource | 5 g Galactomune proprietary prebiotic blend per scoop; individual GOS and beta-glucan quantities not disclosedSource | 6 g per servingSource |
| Dose-to-trial fitA named ingredient is not enough when the retail amount is far below the studied dose. | Comparable value not available | Comparable value not available | Comparable value not available | Comparable value not available | Comparable value not available | Human scFOS dose-response research tested 2.5, 5, 7.5 and 10 g/day; 5 g/day increased bifidobacteria versus baseline and 10 g/day produced the largest responseSource | Human randomized evidence found increased Bifidobacterium at 1.4 and 2.8 g XOS/day; the current retail serving of 2.2 g falls between those studied dosesSource | Comparable value not available | Comparable value not available | Cannot match the product to 2.75 g B-GOS symptom research or ≥3 g oat beta-glucan cholesterol research because the component amounts and beta-glucan structure/source differSource | Comparable value not available |
| Product-specific trial signalProduct-specific evidence is stronger than transferring results from a related ingredient, but it can still be endpoint- or population-specific. | Comparable value not available | Comparable value not available | Comparable value not available | 30 g/day for 12 weeks significantly increased Bifidobacterium in both middle-aged and adults age 70+ versus placebo; older adults also had a small increase in fecal butyrateSource | Comparable value not available | Comparable value not available | Comparable value not available | Comparable value not available | Comparable value not available | Comparable value not available | Comparable value not available |
| Research statusWhether the record is desk-researched, hands-on tested or lab measured | Evidence mapped | Evidence mapped | Evidence mapped | Product trial mixed results | Evidence mapped | Evidence mapped | Evidence mapped | Evidence mapped | Evidence mapped | Evidence mapped | Evidence mapped |
| Last checked | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 | 2026-08-12 |
Product labels can change; follow the current package. When a comparable field is missing, the table says so rather than substituting a differently defined number.
Start with the substrate
XOS, FOS, GOS, PHGG, resistant maltodextrin, acacia, HMOs, resistant starch and beta-glucans are different substrates. Evidence for one should not be transferred automatically to another.
The comparison table identifies the substrate first so products with very different fermentation and evidence profiles are not treated as interchangeable.
Check the dose against the study
A label may use the same ingredient name as a clinical trial while providing a substantially different amount. Compare the retail dose in grams or milligrams with the dose used in the cited human study.
A close dose match still does not guarantee the same result: population, duration and endpoint also matter.
Read missing cells literally
A blank comparison field means a comparable sourced value has not been established in the current product record. It should not be filled with a differently defined number simply to make the table look complete.
Use the prebiotic guide for the evidence and tolerability differences among these substrate families.
Source trail
Primary documents and supporting evidence
- World Gastroenterology Organisation Global Guideline: Probiotics and PrebioticsWorld Gastroenterology Organisation · Clinical guideline · retrieved 2026-08-12
- ISAPP consensus statement on the definition and scope of prebioticsNature Reviews Gastroenterology & Hepatology / PubMed · Expert consensus · retrieved 2026-08-11
- Randomized clinical study: partially hydrolyzed guar gum versus placebo in irritable bowel syndromeNutrition & Metabolism · Professional health · retrieved 2026-08-12
- NOW Prebiotic Bifido Boost Powder — official product informationNOW Foods · Manufacturer · retrieved 2026-08-12
- Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiotaFood & Function · Professional health · retrieved 2026-08-12